KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 161 filers reported holding KARUNA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $220,320 | -3.4% | 1,016 | +0.3% | 0.01% | -37.5% |
| Q3 2022 | $228,000 | -93.5% | 1,013 | -96.3% | 0.01% | -94.7% |
| Q2 2022 | $3,500,000 | +2.0% | 27,663 | +2.2% | 0.15% | +15.4% |
| Q1 2022 | $3,431,000 | -3.2% | 27,063 | 0.0% | 0.13% | +4.0% |
| Q4 2021 | $3,545,000 | +7.1% | 27,063 | 0.0% | 0.12% | -4.6% |
| Q3 2021 | $3,311,000 | +7.3% | 27,063 | 0.0% | 0.13% | +3.1% |
| Q2 2021 | $3,085,000 | -45.5% | 27,063 | -42.5% | 0.13% | -52.1% |
| Q1 2021 | $5,658,000 | +2.0% | 47,063 | -13.8% | 0.26% | -8.3% |
| Q4 2020 | $5,548,000 | +27.5% | 54,612 | -3.0% | 0.29% | -4.0% |
| Q3 2020 | $4,353,000 | -48.8% | 56,302 | -26.2% | 0.30% | -50.9% |
| Q2 2020 | $8,503,000 | – | 76,284 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
| Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
| Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
| Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
| First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
| Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
| Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
| Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
| DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |